Back to search

Article

A Novel Hyperinflammation Clinical Risk Tool, HI5-NEWS2, Predicts Mortality Following Early Dexamethasone Use in an Observational Cohort of Hospitalised COVID-19 Patients

2021-05-27

Abstract excerpt

Background: The success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of Sars-CoV-2 infection may predominantly reflect its anti-inflammatory action against a hyperinflammation (HI) response. It is likely that there is substantial heterogeneity in HI responses in COVID-19.<br><br>Methods: Blood CRP, ferritin, neutrophil, lymphocyte and platelet counts were scored to assess HI (HI5) an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7b336a8c-f01b-5e2b-b231-1e539832d5ca
DOI
10.2139/ssrn.3854746
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Novel Hyperinflammation Clinical Risk Tool, HI5-NEWS2, Predicts Mortality Following Early Dexamethasone Use in an Observational Cohort of Hospitalised COVID-19 PatientsDOI 10.2139/ssrn.3854746
Select a neighboring publication to make it the new centre.